Veracyte Inc (VCYT)
35.02
+0.71
(+2.07%)
USD |
NASDAQ |
Nov 04, 16:00
35.70
+0.68
(+1.94%)
After-Hours: 06:26
Veracyte Price to Book Value: 2.375 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 2.375 |
| November 01, 2024 | 2.327 |
| October 31, 2024 | 2.288 |
| October 30, 2024 | 2.374 |
| October 29, 2024 | 2.332 |
| October 28, 2024 | 2.314 |
| October 25, 2024 | 2.240 |
| October 24, 2024 | 2.223 |
| October 23, 2024 | 2.201 |
| October 22, 2024 | 2.211 |
| October 21, 2024 | 2.246 |
| October 18, 2024 | 2.336 |
| October 17, 2024 | 2.327 |
| October 16, 2024 | 2.355 |
| October 15, 2024 | 2.311 |
| October 14, 2024 | 2.301 |
| October 11, 2024 | 2.307 |
| October 10, 2024 | 2.189 |
| October 09, 2024 | 2.165 |
| October 08, 2024 | 2.271 |
| October 07, 2024 | 2.297 |
| October 04, 2024 | 2.227 |
| October 03, 2024 | 2.236 |
| October 02, 2024 | 2.292 |
| October 01, 2024 | 2.247 |
| Date | Value |
|---|---|
| September 30, 2024 | 2.309 |
| September 27, 2024 | 2.290 |
| September 26, 2024 | 2.273 |
| September 25, 2024 | 2.262 |
| September 24, 2024 | 2.288 |
| September 23, 2024 | 2.324 |
| September 20, 2024 | 2.362 |
| September 19, 2024 | 2.391 |
| September 18, 2024 | 2.290 |
| September 17, 2024 | 2.328 |
| September 16, 2024 | 2.281 |
| September 13, 2024 | 2.233 |
| September 12, 2024 | 2.063 |
| September 11, 2024 | 2.056 |
| September 10, 2024 | 2.017 |
| September 09, 2024 | 1.972 |
| September 06, 2024 | 1.938 |
| September 05, 2024 | 2.019 |
| September 04, 2024 | 2.004 |
| September 03, 2024 | 2.054 |
| August 30, 2024 | 2.140 |
| August 29, 2024 | 2.166 |
| August 28, 2024 | 2.145 |
| August 27, 2024 | 2.170 |
| August 26, 2024 | 2.193 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.017
Minimum
May 11 2022
12.90
Maximum
Feb 09 2021
3.23
Average
1.976
Median
Price to Book Value Benchmarks
| Fonar Corp | 0.566 |
| XWELL Inc | 1.043 |
| ProPhase Labs Inc | 0.948 |
| Applied DNA Sciences Inc | 0.1521 |
| OncoCyte Corp | 2.150 |
Price to Book Value Related Metrics
| PS Ratio | 6.526 |
| PEG Ratio | -0.5336 |
| Price to Free Cash Flow | 64.98 |
| Price | 35.02 |
| Earnings Yield | -2.14% |
| Market Cap | 2.690B |
| PEGY Ratio | -0.5336 |
| Operating PE Ratio | 1278.23 |
| Normalized PE Ratio | 246.89 |